Stepwise evolution of Salmonella Typhimurium ST313 causing bloodstream infection in Africa
-
Published:2020-12-21
Issue:3
Volume:6
Page:327-338
-
ISSN:2058-5276
-
Container-title:Nature Microbiology
-
language:en
-
Short-container-title:Nat Microbiol
Author:
Pulford Caisey V.ORCID, Perez-Sepulveda Blanca M., Canals RocíoORCID, Bevington Jessica A.ORCID, Bengtsson Rebecca J., Wenner Nicolas, Rodwell Ella V., Kumwenda BenjaminORCID, Zhu XiaojunORCID, Bennett Rebecca J.ORCID, Stenhouse George E.ORCID, Malaka De Silva P., Webster Hermione J., Bengoechea Jose A.ORCID, Dumigan AmyORCID, Tran-Dien Alicia, Prakash Reenesh, Banda Happy C., Alufandika Lovemore, Mautanga Mike P., Bowers-Barnard Arthur, Beliavskaia Alexandra Y., Predeus Alexander V.ORCID, Rowe Will P. M., Darby Alistair C., Hall Neil, Weill François-XavierORCID, Gordon Melita A., Feasey Nicholas A., Baker Kate S.ORCID, Hinton Jay C. D.ORCID
Abstract
AbstractBloodstream infections caused by nontyphoidal Salmonella are a major public health concern in Africa, causing ~49,600 deaths every year. The most common Salmonella enterica pathovariant associated with invasive nontyphoidal Salmonella disease is Salmonella Typhimurium sequence type (ST)313. It has been proposed that antimicrobial resistance and genome degradation has contributed to the success of ST313 lineages in Africa, but the evolutionary trajectory of such changes was unclear. Here, to define the evolutionary dynamics of ST313, we sub-sampled from two comprehensive collections of Salmonella isolates from African patients with bloodstream infections, spanning 1966 to 2018. The resulting 680 genome sequences led to the discovery of a pan-susceptible ST313 lineage (ST313 L3), which emerged in Malawi in 2016 and is closely related to ST313 variants that cause gastrointestinal disease in the United Kingdom and Brazil. Genomic analysis revealed degradation events in important virulence genes in ST313 L3, which had not occurred in other ST313 lineages. Despite arising only recently in the clinic, ST313 L3 is a phylogenetic intermediate between ST313 L1 and L2, with a characteristic accessory genome. Our in-depth genotypic and phenotypic characterization identifies the crucial loss-of-function genetic events that occurred during the stepwise evolution of invasive S. Typhimurium across Africa.
Publisher
Springer Science and Business Media LLC
Subject
Cell Biology,Microbiology (medical),Genetics,Applied Microbiology and Biotechnology,Immunology,Microbiology
Reference89 articles.
1. Stanaway, J. D. et al. The global burden of non-typhoidal salmonella invasive disease: a systematic analysis for the Global Burden of Disease Study 2017. Lancet Infect. Dis. 19, 1312–1324 (2019). 2. Feasey, N. A., Dougan, G., Kingsley, R. A., Heyderman, R. S. & Gordon, M. A. Invasive non-typhoidal salmonella disease: an emerging and neglected tropical disease in Africa. Lancet 379, 2489–2499 (2012). 3. Marchello, C. S., Dale, A. P., Pisharody, S., Rubach, M. P. & Crump, J. A. A systematic review and meta-analysis of the prevalence of community-onset bloodstream infections among hospitalized patients in Africa and Asia. Antimicrob. Agents Chemother. 64, e01974–19 (2019). 4. Reddy, E. A., Shaw, A. V. & Crump, J. A. Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. Lancet Infect. Dis. 10, 417–432 (2010). 5. Kingsley, R. A. et al. Epidemic multiple drug resistant Salmonella Typhimurium causing invasive disease in sub-Saharan Africa have a distinct genotype. Genome Res. 19, 2279–2287 (2009).
Cited by
80 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|